Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Nov. 15, 2021, 4:41 a.m. EST

Philips shares tumble as FDA raises concern about silicone foam

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Koninklijke Philips N.V. (PHIA)
  • X
    Koninklijke Philips N.V. ADR (PHG)

or Cancel Already have a watchlist? Log In

By Steve Goldstein

Koninklijke Philips /zigman2/quotes/204604645/delayed NL:PHIA -0.27% /zigman2/quotes/200778575/composite PHG +0.26% was on track for its worst single session in 19 years, falling 9.6%, after the Food and Drug Administration's inspection of a U.S. facility, following a recall of breathing assistance machines. The FDA said it obtained information during an inspection about the silicone-based foam used in a similar device marketed outside the U.S., which failed one safety test for the release of certain chemicals . "The FDA is aware that patients have already received devices with silicone-based foam as part of the repair and replace program. At this time, the agency does not have sufficient information to conclude whether the silicone-based foam being used in the repaired devices poses any risk to patients in the U.S.," the agency said. Philips said it's conducted testing to support the new silicone replacement form, which it said demonstrated acceptable results, and will continue to coordinate with the FDA.

/zigman2/quotes/204604645/delayed
NL : Netherlands: Euronext Amsterdam
29.93
-0.08 -0.27%
Volume: 3.84M
Jan. 20, 2022 5:37p
P/E Ratio
24.24
Dividend Yield
2.84%
Market Cap
€26.38 billion
Rev. per Employee
€233,332
loading...
/zigman2/quotes/200778575/composite
US : U.S.: NYSE
$ 34.17
+0.09 +0.26%
Volume: 2.59M
Jan. 20, 2022 3:02p
P/E Ratio
23.31
Dividend Yield
2.58%
Market Cap
$29.93 billion
Rev. per Employee
$277,845
loading...

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.